RecruitingNot ApplicableNCT07511387

Efficacy of a Novel Myopia Defocus Spectacle Lens in School-Aged Children

A Pilot Study on the Short-Term Efficacy of a Novel Myopia Defocus Spectacle Lens in School-Aged Children


Sponsor

The Hong Kong Polytechnic University

Enrollment

40 participants

Start Date

Apr 10, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to evaluate the short-term efficacy and safety of a novel, proprietary spectacle lens. Forty myopic participants, aged 6 to 15 years, will be prescribed with the study spectacles for a period of six months. All subjects will be required to attend five scheduled visits. Change in subfoveal choroidal thickness (SfChT), axial length and refraction will be determined.


Eligibility

Min Age: 6 YearsMax Age: 15 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying BCMC lens for people with myopia. The study is currently recruiting participants at 1 location. People eligible for this study include aged 6 Years to 15 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBCMC lens

BLMC spectacle lens is a spectacle lens that corrects the distance refraction and provides defocus in peripheral region


Locations(1)

School of Optometry, The Hong Kong Polytechnic University

Hong Kong, Hong Kong

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07511387


Related Trials